Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
American Journal of Cancer Research
|
February 12, 2021
A heterogeneous cellular response to ionizing radiation revealed by single cell transcriptome sequencing
Yan Gao, Qingke Duan, Ning Wu, et al.
Scientific Reports
|
October 12, 2017
Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry
Qingke Duan, Hengqiang Zhao, Zhengle Zhang, et al.
Journal of Cellular and Molecular Medicine
|
March 1, 2017
Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
Hengqiang Zhao, Qingke Duan, Zhengle Zhang, et al.
International Journal of Biological Sciences
|
March 9, 2026
Interaction between m6A and YAP1 mechanotransduction pathways is essential for mechanical memory and matrix remodeling in pancreatic cancer
Jiaoshun Chen, Gengqiao Wang, Haoxiang Zhang, et al.
Cancer Letters
|
August 31, 2016
Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
Zhengle Zhang, Qingke Duan, Hengqiang Zhao, et al.
Molecular Therapy Oncolytics
|
September 12, 2019
ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
Hengqiang Zhao, Shihong Wu, Hehe Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2019
High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway
Qingke Duan, Hehe Li, Chenggang Gao, et al.
Frontiers in Oncology
|
May 28, 2021
Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing
Qingke Duan, Chao Tang, Zhao Ma, et al.
Cell & Bioscience
|
June 28, 2019
Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells
Hehe Li, Zhengle Zhang, Chenggang Gao, et al.
Oncotarget
|
May 14, 2016
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine
Tao Yin, Zhengle Zhang, Bin Cao, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
American Journal of Cancer Research
|
February 12, 2021
A heterogeneous cellular response to ionizing radiation revealed by single cell transcriptome sequencing
Yan Gao, Qingke Duan, Ning Wu, et al.
Scientific Reports
|
October 12, 2017
Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry
Qingke Duan, Hengqiang Zhao, Zhengle Zhang, et al.
Journal of Cellular and Molecular Medicine
|
March 1, 2017
Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
Hengqiang Zhao, Qingke Duan, Zhengle Zhang, et al.
International Journal of Biological Sciences
|
March 9, 2026
Interaction between m6A and YAP1 mechanotransduction pathways is essential for mechanical memory and matrix remodeling in pancreatic cancer
Jiaoshun Chen, Gengqiao Wang, Haoxiang Zhang, et al.
Cancer Letters
|
August 31, 2016
Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
Zhengle Zhang, Qingke Duan, Hengqiang Zhao, et al.
Molecular Therapy Oncolytics
|
September 12, 2019
ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
Hengqiang Zhao, Shihong Wu, Hehe Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2019
High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway
Qingke Duan, Hehe Li, Chenggang Gao, et al.
Frontiers in Oncology
|
May 28, 2021
Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing
Qingke Duan, Chao Tang, Zhao Ma, et al.
Cell & Bioscience
|
June 28, 2019
Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells
Hehe Li, Zhengle Zhang, Chenggang Gao, et al.
Oncotarget
|
May 14, 2016
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine
Tao Yin, Zhengle Zhang, Bin Cao, et al.
Page
of 1